Research ArticleArticle
Infigratinib Is a Reversible Inhibitor and Mechanism-Based Inactivator of Cytochrome P450 3A4
Lloyd Wei Tat Tang, Jian Wei Teng, Ravi Kumar Verma, Siew Kwan Koh, Lei Zhou, Mei Lin Go, Hao Fan and Eric Chun Yong Chan
Drug Metabolism and Disposition September 2021, 49 (9) 856-868; DOI: https://doi.org/10.1124/dmd.121.000508
Lloyd Wei Tat Tang
Department of Pharmacy, Faculty of Science (L.W.T.T., J.W.T, M.L.G., E.C.Y.C.) and Department of Ophthalmology, Yong Loo Lin School of Medicine (L.Z.), National University of Singapore, Singapore; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore (R.K.V., H.F.); Singapore Eye Research Institute, Singapore (S.K.K., L.Z.); and Ophthalmology and Visual Sciences Academia Clinical Program, Duke-National University of Singapore Medical School, Singapore (L.Z.)
Jian Wei Teng
Department of Pharmacy, Faculty of Science (L.W.T.T., J.W.T, M.L.G., E.C.Y.C.) and Department of Ophthalmology, Yong Loo Lin School of Medicine (L.Z.), National University of Singapore, Singapore; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore (R.K.V., H.F.); Singapore Eye Research Institute, Singapore (S.K.K., L.Z.); and Ophthalmology and Visual Sciences Academia Clinical Program, Duke-National University of Singapore Medical School, Singapore (L.Z.)
Ravi Kumar Verma
Department of Pharmacy, Faculty of Science (L.W.T.T., J.W.T, M.L.G., E.C.Y.C.) and Department of Ophthalmology, Yong Loo Lin School of Medicine (L.Z.), National University of Singapore, Singapore; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore (R.K.V., H.F.); Singapore Eye Research Institute, Singapore (S.K.K., L.Z.); and Ophthalmology and Visual Sciences Academia Clinical Program, Duke-National University of Singapore Medical School, Singapore (L.Z.)
Siew Kwan Koh
Department of Pharmacy, Faculty of Science (L.W.T.T., J.W.T, M.L.G., E.C.Y.C.) and Department of Ophthalmology, Yong Loo Lin School of Medicine (L.Z.), National University of Singapore, Singapore; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore (R.K.V., H.F.); Singapore Eye Research Institute, Singapore (S.K.K., L.Z.); and Ophthalmology and Visual Sciences Academia Clinical Program, Duke-National University of Singapore Medical School, Singapore (L.Z.)
Lei Zhou
Department of Pharmacy, Faculty of Science (L.W.T.T., J.W.T, M.L.G., E.C.Y.C.) and Department of Ophthalmology, Yong Loo Lin School of Medicine (L.Z.), National University of Singapore, Singapore; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore (R.K.V., H.F.); Singapore Eye Research Institute, Singapore (S.K.K., L.Z.); and Ophthalmology and Visual Sciences Academia Clinical Program, Duke-National University of Singapore Medical School, Singapore (L.Z.)
Mei Lin Go
Department of Pharmacy, Faculty of Science (L.W.T.T., J.W.T, M.L.G., E.C.Y.C.) and Department of Ophthalmology, Yong Loo Lin School of Medicine (L.Z.), National University of Singapore, Singapore; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore (R.K.V., H.F.); Singapore Eye Research Institute, Singapore (S.K.K., L.Z.); and Ophthalmology and Visual Sciences Academia Clinical Program, Duke-National University of Singapore Medical School, Singapore (L.Z.)
Hao Fan
Department of Pharmacy, Faculty of Science (L.W.T.T., J.W.T, M.L.G., E.C.Y.C.) and Department of Ophthalmology, Yong Loo Lin School of Medicine (L.Z.), National University of Singapore, Singapore; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore (R.K.V., H.F.); Singapore Eye Research Institute, Singapore (S.K.K., L.Z.); and Ophthalmology and Visual Sciences Academia Clinical Program, Duke-National University of Singapore Medical School, Singapore (L.Z.)
Eric Chun Yong Chan
Department of Pharmacy, Faculty of Science (L.W.T.T., J.W.T, M.L.G., E.C.Y.C.) and Department of Ophthalmology, Yong Loo Lin School of Medicine (L.Z.), National University of Singapore, Singapore; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore (R.K.V., H.F.); Singapore Eye Research Institute, Singapore (S.K.K., L.Z.); and Ophthalmology and Visual Sciences Academia Clinical Program, Duke-National University of Singapore Medical School, Singapore (L.Z.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Inhibition and Inactivation of CYP3A4 by Infigratinib
Lloyd Wei Tat Tang, Jian Wei Teng, Ravi Kumar Verma, Siew Kwan Koh, Lei Zhou, Mei Lin Go, Hao Fan and Eric Chun Yong Chan
Drug Metabolism and Disposition September 1, 2021, 49 (9) 856-868; DOI: https://doi.org/10.1124/dmd.121.000508
Research ArticleArticle
Inhibition and Inactivation of CYP3A4 by Infigratinib
Lloyd Wei Tat Tang, Jian Wei Teng, Ravi Kumar Verma, Siew Kwan Koh, Lei Zhou, Mei Lin Go, Hao Fan and Eric Chun Yong Chan
Drug Metabolism and Disposition September 1, 2021, 49 (9) 856-868; DOI: https://doi.org/10.1124/dmd.121.000508
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement